Komori
Kokusai (7722) · RiskMitigated

Decrease in valuation difference due to a decline in the market value of shares held

First written in FY2019-Q1. 12 of 27 entries say "Mitigated", first in FY2020-Q1. Latest entry: 2026-08-07.

27entries
9years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMitigatedFY2025-H1 – 2026-08-072018: 220182019: 420192020: 420202021: 320212022: 320222023: 320232024: 320242025: 220252026: 32026
Same theme, other companies
Changes in Net Assets, Valuation Differences, etc.A theme 75 companies write about · 36 as a headwind · 30 as a tailwind

Kokusai moved to the "Worse" side of this theme in 2023, 1 year after the typical company in this theme (2022).

The whole theme swung hardest in 2022: 11 of 61 companies on the "Worse" side.

9 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 75 companies compared. The sentences above are computed from all 75.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-07MitigatedResults

    「有価証券の時価上昇に伴い、その他有価証券評価差額金が増加(前連結会計年度末比8千1百万円増)したものの、配当金を支払ったことにより利益剰余金が減少(前連結会計年度末比2億1千9百万円減)したことが主たる要因であります。」

    その他有価証券評価差額金は有価証券の時価上昇により前期末比8,100万円増加した。
  2. FY2026MitigatedAnnual report

    「Valuation difference on available-for-sale securities 151,316 181,447」

    The valuation difference on available-for-sale securities increased by ¥30.13 million, from ¥151.316 million at the end of the previous fiscal year to ¥181.447 million, turning from a decline through the previous fiscal year to an increase.
  3. 2026-05-15MitigatedResults

    「株価の上昇により投資有価証券が増加(前連結会計年度末比5千万円増)した」

    株価上昇により投資有価証券が増加し、その他有価証券評価差額金も前期末の1億5,131万6千円から1億8,144万7千円へ増加した。
  4. FY2026-H1MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ 23,136 27,296」

    The valuation difference on available-for-sale securities turned from a ¥23.136 million decline in the previous year's interim period to a ¥27.296 million increase in the current interim consolidated accounting period.
  5. FY2025MitigatedAnnual report

    「Valuation difference on available-for-sale securities 167,887 151,316」

    The valuation difference on available-for-sale securities decreased by ¥16.57 million from the end of the previous fiscal year, but the decline was smaller than the ¥82.513 million decrease in the previous fiscal year.
  6. FY2025-H1MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ 38,835 △ 23,136」

    The decline in the valuation difference on available-for-sale securities narrowed from ¥38.835 million in the previous year's interim period to ¥23.136 million. The decline itself continued.
  7. FY2024WorsenedAnnual report

    「Valuation difference on available-for-sale securities 250,400 167,887」

    The valuation difference on available-for-sale securities decreased by ¥82.513 million, from ¥250.4 million at the end of the previous fiscal year to ¥167.887 million, as the decline caused by falling market values of held shares continued.
  8. FY2024-Q3WorsenedAnnual report

    「Valuation difference on available-for-sale securities 250,400 166,881」

    The valuation difference on available-for-sale securities decreased by ¥83.519 million, from ¥250.4 million at the end of the previous consolidated fiscal year to ¥166.881 million.
  9. FY2024-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities △ 18,179 △ 38,835」

    The valuation difference on available-for-sale securities decreased by ¥38.835 million, compared with a ¥18.179 million decline in the same period of the previous year, so the decrease widened.
  10. FY2024-Q1RestatedAnnual report

    「Valuation difference on available-for-sale securities 250,400 227,716」

    The valuation difference on available-for-sale securities decreased by ¥22.684 million from the end of the previous consolidated fiscal year, as the decline associated with falling market values of held shares continued.
  11. FY2023-Q3WorsenedAnnual report

    「Valuation difference on available-for-sale securities 219,527 196,006」

    The valuation difference on available-for-sale securities decreased by ¥23.521 million from the end of the previous consolidated fiscal year, confirming a continued decline caused by falling market values of held shares, as in the previous quarter.
  12. FY2023-Q2RestatedAnnual report

    「Valuation difference on available-for-sale securities 219,527 201,348」

    The valuation difference on available-for-sale securities decreased by ¥18.179 million from the end of the previous consolidated fiscal year, as the decline caused by falling market values of held shares continued.
  13. FY2023-Q1WorsenedAnnual report

    「The primary factor was a decrease in the valuation difference on available-for-sale securities as the market value of held shares declined (down ¥17 million from the end of the previous consolidated fiscal year).」

    The valuation difference on available-for-sale securities, which had increased through the previous quarter, turned to a ¥17.6 million decline as the market value of held shares fell.
  14. FY2022-Q3Smaller increase in valuation differenceAnnual report

    「The valuation difference on available-for-sale securities increased (up ¥66 million from the end of the previous consolidated fiscal year).」

    The valuation difference on available-for-sale securities continued to increase, but the increase narrowed from ¥106 million in the previous quarter to ¥66 million.
  15. FY2022-Q2MitigatedAnnual report

    「The valuation difference on available-for-sale securities increased (up ¥106 million from the end of the previous consolidated fiscal year).」

    The valuation difference on available-for-sale securities increased by ¥106 million from the end of the previous consolidated fiscal year, and the decline caused by falling share prices did not continue.
  16. FY2022-Q1MitigatedAnnual report

    「The valuation difference on available-for-sale securities increased (up ¥63 million from the end of the previous consolidated fiscal year).」

    The valuation difference on available-for-sale securities increased by ¥63.49 million from the end of the previous consolidated fiscal year, and the decline caused by falling share prices did not continue.
  17. FY2021-Q3Wider increase in valuation differenceAnnual report

    「The valuation difference on available-for-sale securities increased (up ¥132 million from the end of the previous consolidated fiscal year), although」

    The valuation difference on available-for-sale securities increased by ¥132 million from the end of the previous consolidated fiscal year, and the decline in the valuation difference caused by falling share prices did not continue.
  18. FY2021-Q2MitigatedAnnual report

    「Valuation difference on available-for-sale securities 233,582 294,616」

    The valuation difference on available-for-sale securities increased by ¥61.03 million from the end of the previous consolidated fiscal year, and the risk of a decline in the valuation difference eased following the increase in FY2021-Q1.
  19. FY2021-Q1MitigatedAnnual report

    「The valuation difference on available-for-sale securities increased (up ¥23 million from the end of the previous consolidated fiscal year), although」

    The valuation difference on available-for-sale securities increased by ¥23 million from the end of the previous consolidated fiscal year, reversing the decline seen in the previous year.
  20. FY2020Slight decline in the valuation differenceAnnual report

    「The valuation difference on available-for-sale securities decreased (down ¥5 million from the end of the previous consolidated fiscal year).」

    The valuation difference on available-for-sale securities decreased by ¥52.15 million from the end of the previous consolidated fiscal year, a smaller decline than the ¥128 million decrease in the previous consolidated fiscal year.
  21. FY2020-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities 238,797 334,198」

    The valuation difference on available-for-sale securities increased by ¥95.4 million from the end of the previous consolidated fiscal year, reversing the slight decline through the previous quarter.
  22. FY2020-Q2Slight decline in the valuation differenceAnnual report

    「Valuation difference on available-for-sale securities 238,797 238,369」

    The valuation difference on available-for-sale securities decreased by ¥428,000 from the end of the previous consolidated fiscal year, turning to a slight decline after increasing through the previous quarter.
  23. FY2020-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities 238,797 258,037」

    The valuation difference on available-for-sale securities increased by ¥19.24 million from the end of the previous consolidated fiscal year, reversing the decline caused by falling market values that continued in the previous year.
  24. FY2019Full-year decrease in valuation differenceAnnual report

    「The primary factors were a decrease in the valuation difference on available-for-sale securities as the market value of held shares declined (down ¥128 million from the end of the previous consolidated fiscal year) and a decrease in the foreign currency translation adjustment account (down ¥78 million from the end of the previous consolidated fiscal year).」

    The valuation difference on available-for-sale securities also decreased over the full year as the market value of held shares declined.
  25. FY2019-Q3WorsenedAnnual report

    「The primary factor was a decrease in the valuation difference on available-for-sale securities as the market value of held shares declined (down ¥202 million from the end of the previous consolidated fiscal year).」

    The valuation difference on available-for-sale securities continued to decline as the market value of held shares fell, with the decrease widening from ¥69 million in the second quarter to ¥202 million.
  26. FY2019-Q2Continued decrease in valuation difference, but with a smaller declineAnnual report

    「The primary factor was a decrease in the valuation difference on available-for-sale securities as the market value of held shares declined (down ¥69 million from the end of the previous consolidated fiscal year).」

    The valuation difference on available-for-sale securities continued to decline as the market value of held shares fell. The decrease was ¥69 million, smaller than the ¥116 million decline in the first quarter.
  27. FY2019-Q1First statedAnnual report

    「The primary factor was a decrease in the valuation difference on available-for-sale securities as the market value of held shares declined (down ¥116 million from the end of the previous consolidated fiscal year).」

    The market value of held shares actually declined, reducing the valuation difference on available-for-sale securities by ¥116 million.
Moved together

"Quarterly Performance: Lower Sales, Lower Profit and Shift into Loss" moved the same way as this thread, in the same document, in 13 of its 27 moves.

13119875★123456
  1. ★This thread
  2. 1Quarterly Performance: Lower Sales, Lower Profit and Shift into Loss13×
  3. 2Decline in Sales and Ordinary Profit in the Japan (国際計測器) Segment11×
  4. 3Sluggish Orders for Materials Testing Machines for the Nuclear Industry9×
  5. 4Decline in Equity Ratio8×
  6. 5China segment: lower revenue and lower profit7×
  7. 6Robust shipments of large-scale projects to North America5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Kokusai's next results are scheduled for 2026-11-09. Read the earnings preview It last moved in the Results of 2026-08-07: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.